Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.25%
1,104.10
+2.73
+0.25%
1,101.371,103.631,105.311,091.41
SIXC
Communications
SIXC
Communications
SIXC
-1.50%
604.16
-9.19
-1.50%
613.35613.35613.35601.49
SIXE
Energy
SIXE
Energy
SIXE
-0.09%
1,197.81
-1.02
-0.09%
1,198.831,199.681,199.751,182.41
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,740.41
-15.54
-0.88%
1,755.951,754.061,756.031,734.69
SIXM
Financials
SIXM
Financials
SIXM
-0.64%
634.44
-4.07
-0.64%
638.51637.41637.41633.05
SIXR
Staples
SIXR
Staples
SIXR
-0.31%
840.90
-2.62
-0.31%
843.52843.35846.40837.93
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.38%
215.13
-0.82
-0.38%
215.95215.95216.84215.06
SIXT
Technology
SIXT
Technology
SIXT
+2.86%
3,228.71
+89.80
+2.86%
3,138.913,189.303,230.853,174.76
SIXU
Utilities
SIXU
Utilities
SIXU
+0.16%
935.87
+1.50
+0.16%
934.37934.72938.26927.50
SIXV
Health care
SIXV
Health care
SIXV
-1.37%
1,457.12
-20.31
-1.37%
1,477.431,474.121,474.121,451.80
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.83%
2,399.84
+19.65
+0.83%
2,380.192,389.342,403.042,380.47
XBIT:NASDAQ
XBiotech Inc
$2.51
-0.79%
(-0.020) 1D
Apr 24, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for XBIT...
Open
$2.56
High
$2.60
Low
$2.41
Mkt. cap
76.52M
Avg. vol.
40.85K
Volume
15.90K
52-wk high
$3.61
52-wk low
$2.09
EPS
-$1.49
Beta
0.86
Shares outstanding
30.49M
No. of employees
85
News stories
From sources across the web
Profile
XBiotech Inc. is a clinical-stage biopharmaceutical company based in Austin, Texas. It specializes in the research and development of human-derived antibody therapeutics for multiple diseases, including cancer, rheumatological, and infectious diseases. Wikipedia
About XBiotech Inc
CEO-
Employees85
Founded2005
HeadquartersAustin, Texas, United States
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
11.62M
5.34M
5.08M
25.36M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.93M
1.00M
967.00K
4.40M
Operating expense
13.55M
6.34M
6.05M
29.76M
Total operating expenses
13.55M
6.34M
6.05M
29.76M
Operating income
-13.55M
-6.34M
-6.05M
-29.76M
Other non operating income
995.00K
-3.00K
-85.00K
-8.00K
EBT including unusual items
-10.86M
-1.73M
-5.91M
-26.82M
EBT excluding unusual items
-10.86M
-1.73M
-5.91M
-27.37M
Income tax expense
29.00K
28.00K
102.00K
76.00K
Effective tax rate
-0.27%
-1.62%
-1.73%
-0.28%
Other operating expenses
-
-
-
-
Net income
-10.88M
-1.76M
-6.01M
-26.89M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
1.50M
1.53M
1.43M
1.22M
Interest expense
-88.00K
-
-
-
Net interest expenses
1.42M
1.53M
1.43M
1.22M
Depreciation and amortization charges
-
-
-
-
EBITDA
-13.11M
-5.90M
-5.62M
-29.38M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more